Page 111 - Read Online
P. 111

Page 6 of 12                        Schofield et al. J Cancer Metastasis Treat 2020;6:10  I  http://dx.doi.org/10.20517/2394-4722.2019.43

               Table 2. Alpha-enolase controls cancer cell proliferation and survival
                Cancer               Experimental model         Effect of modulation of ENO1 expression  Ref.
                Bladder cancer  Overexpression and knockdown in   Knockdown decreased cell proliferation and colony formation.   [59]
                                T253 and 5637 cells      Overexpression increased cell proliferation and colony
                                                         formation
                Breast cancer   Downregulation in MDA-MB-231   Downregulation decreased cell proliferation and survival in   [62]
                                cells                    vitro and reduced tumour growth in vivo
                Colorectal cancer  Overexpression and knockdown in   Overexpression promoted cell proliferation and tumour growth   [11]
                                HCT116 cells             in vivo; Decreased expression decreased cell proliferation and
                                                         tumour growth in vivo
                Endometrial carcinoma Knockdown in HEC-1B and Ishikawa  Decreased expression reduced cell proliferation in vitro and   [12]
                                                         tumourigenesis in vivo
                Gastric cancer  Knockdown in MGC-803 and MKN45 Knockdown led to cell cycle arrest at the G 1  phase and   [13]
                                cells                    promoted apoptosis, and repressed the rate of cell
                                                         proliferation and colony formation
                                Knockdown in MKN45 cells  Knockdown decreased cell proliferation, induced apoptosis   [64]
                                                         and increased sensitivity to chemotherapeutics
                                Knockdown in AGS cells and   Knockdown decreased proliferation and colony formation,   [60]
                                overexpression in SGC7901 cells  whereas overexpression increased cell proliferation and colony
                                                         formation
                                Overexpression in AGS cells  Overexpression increased cell proliferation and colony   [61]
                                                         formation
                Glioma          Knockdown in U-87MG cells  Knockdown suppressed cell proliferation and colony formation   [6]
                                                         in vitro and tumour growth in vivo
                HCC             Knockdown in HCC cells   Knockdown inhibited cell growth             [58]
                Lung cancer     Knockdown in NCI-H441 cells  Knockdown decreased cell proliferation and survival  [62]
                Pancreatic cancer  Knockdown in CFPAC-1 cells  Downregulation decreased cell proliferation and survival in   [62]
                                                         vitro and reduced tumour growth in vivo
                Retinoblastoma  Knockdown in Y79 cells and   Knockdown led to cell cycle arrest at the G 1  phase, decreased   [57]
                                overexpression in Meri-RB1 cells  cell proliferation and increased apoptosis. Overexpression
                                                         increased cell proliferation.

               HCC: hepatocellular carcinoma






























               Figure 3. Alpha-enolase acts as a surface plasminogen-binding receptor to mediate cancer cell invasion and metastasis formation. PLG
               binds to its receptors and is subsequently converted to PLIN by plasminogen activators (e.g., uPA). Cell surface-associated plasmin
               facilitates degradation of the ECM, allowing tumour cells to invade and metastasise into other tissues. PLG: plasminogen; PLIN: plasmin;
               ECM: extracellular matrix; uPA: urokinase-type plasminogen activator
   106   107   108   109   110   111   112   113   114   115   116